Becton, Dickinson and Company (NYSE:BDX - Get Free Report) EVP Richard Byrd sold 459 shares of the firm's stock in a transaction on Tuesday, March 18th. The stock was sold at an average price of $230.00, for a total value of $105,570.00. Following the completion of the transaction, the executive vice president now owns 6,952 shares in the company, valued at $1,598,960. This represents a 6.19 % decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this hyperlink.
Richard Byrd also recently made the following trade(s):
- On Wednesday, March 12th, Richard Byrd sold 1,940 shares of Becton, Dickinson and Company stock. The stock was sold at an average price of $224.91, for a total value of $436,325.40.
Becton, Dickinson and Company Trading Down 0.5 %
NYSE:BDX traded down $1.22 on Friday, reaching $230.63. The company's stock had a trading volume of 4,372,181 shares, compared to its average volume of 1,539,839. Becton, Dickinson and Company has a 1-year low of $218.75 and a 1-year high of $251.99. The company has a debt-to-equity ratio of 0.69, a quick ratio of 0.63 and a current ratio of 1.13. The firm has a market cap of $66.22 billion, a PE ratio of 38.31, a PEG ratio of 1.63 and a beta of 0.35. The business's 50-day moving average price is $232.58 and its two-hundred day moving average price is $232.04.
Becton, Dickinson and Company (NYSE:BDX - Get Free Report) last posted its earnings results on Wednesday, February 5th. The medical instruments supplier reported $3.43 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of $3.00 by $0.43. Becton, Dickinson and Company had a return on equity of 15.74% and a net margin of 8.47%. Equities research analysts anticipate that Becton, Dickinson and Company will post 14.43 earnings per share for the current fiscal year.
Becton, Dickinson and Company Dividend Announcement
The company also recently disclosed a quarterly dividend, which will be paid on Monday, March 31st. Stockholders of record on Monday, March 10th will be given a dividend of $1.04 per share. The ex-dividend date is Monday, March 10th. This represents a $4.16 annualized dividend and a dividend yield of 1.80%. Becton, Dickinson and Company's dividend payout ratio is currently 69.10%.
Becton, Dickinson and Company declared that its board has authorized a stock repurchase program on Tuesday, January 28th that permits the company to buyback 10,000,000 shares. This buyback authorization permits the medical instruments supplier to repurchase shares of its stock through open market purchases. Shares buyback programs are usually a sign that the company's board of directors believes its shares are undervalued.
Institutional Inflows and Outflows
Several institutional investors and hedge funds have recently modified their holdings of BDX. Norges Bank acquired a new position in shares of Becton, Dickinson and Company during the fourth quarter worth about $735,523,000. T. Rowe Price Investment Management Inc. raised its holdings in Becton, Dickinson and Company by 36.1% during the fourth quarter. T. Rowe Price Investment Management Inc. now owns 12,126,707 shares of the medical instruments supplier's stock worth $2,751,187,000 after acquiring an additional 3,219,317 shares in the last quarter. Kovitz Investment Group Partners LLC raised its holdings in Becton, Dickinson and Company by 392.4% during the fourth quarter. Kovitz Investment Group Partners LLC now owns 3,416,665 shares of the medical instruments supplier's stock worth $775,139,000 after acquiring an additional 2,722,829 shares in the last quarter. Charles Schwab Investment Management Inc. raised its holdings in Becton, Dickinson and Company by 79.0% during the third quarter. Charles Schwab Investment Management Inc. now owns 2,986,543 shares of the medical instruments supplier's stock worth $720,089,000 after acquiring an additional 1,317,723 shares in the last quarter. Finally, First Eagle Investment Management LLC raised its holdings in Becton, Dickinson and Company by 31.4% during the fourth quarter. First Eagle Investment Management LLC now owns 4,426,022 shares of the medical instruments supplier's stock worth $1,004,132,000 after acquiring an additional 1,057,879 shares in the last quarter. 86.97% of the stock is owned by institutional investors and hedge funds.
Wall Street Analyst Weigh In
Several research firms have recently issued reports on BDX. Piper Sandler raised their price target on Becton, Dickinson and Company from $275.00 to $280.00 and gave the stock an "overweight" rating in a research report on Tuesday, January 28th. Barclays raised their price target on Becton, Dickinson and Company from $278.00 to $279.00 and gave the stock an "overweight" rating in a research report on Friday, February 14th. Finally, StockNews.com upgraded Becton, Dickinson and Company from a "hold" rating to a "buy" rating in a research report on Wednesday, March 5th. Eight investment analysts have rated the stock with a buy rating, Based on data from MarketBeat, the stock has an average rating of "Buy" and a consensus price target of $278.29.
Get Our Latest Report on Becton, Dickinson and Company
About Becton, Dickinson and Company
(
Get Free Report)
Becton, Dickinson and Company develops, manufactures, and sells medical supplies, devices, laboratory equipment, and diagnostic products for healthcare institutions, physicians, life science researchers, clinical laboratories, pharmaceutical industry, and the general public worldwide. The company operates in three segments: BD Medical, BD Life Sciences, and BD Interventional.
Further Reading
Before you consider Becton, Dickinson and Company, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Becton, Dickinson and Company wasn't on the list.
While Becton, Dickinson and Company currently has a Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Options trading isn’t just for the Wall Street elite; it’s an accessible strategy for anyone armed with the proper knowledge. Think of options as a strategic toolkit, with each tool designed for a specific financial task. Get this report to learn how options trading can help you use the market’s volatility to your advantage.
Get This Free Report
